MX347154B - Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. - Google Patents

Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Info

Publication number
MX347154B
MX347154B MX2012003180A MX2012003180A MX347154B MX 347154 B MX347154 B MX 347154B MX 2012003180 A MX2012003180 A MX 2012003180A MX 2012003180 A MX2012003180 A MX 2012003180A MX 347154 B MX347154 B MX 347154B
Authority
MX
Mexico
Prior art keywords
infectious diseases
bovine
characteristic
cattle
protein
Prior art date
Application number
MX2012003180A
Other languages
English (en)
Other versions
MX2012003180A (es
Inventor
Fedorovish Licea Navarro Alexei
Félix Olivares Quintero José
Paola Gutiérrez Ordoñez Ana
Original Assignee
Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) filed Critical Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese)
Priority to MX2012003180A priority Critical patent/MX347154B/es
Priority to US14/380,863 priority patent/US9284360B2/en
Priority to PCT/MX2013/000025 priority patent/WO2013125936A2/es
Publication of MX2012003180A publication Critical patent/MX2012003180A/es
Publication of MX347154B publication Critical patent/MX347154B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una proteína de fusión caracterizada porque se compones de: a) una proteína que contiene la secuencia SEQ ID NO. 2; y, b) un antígeno de enfermedades infecciosas, en donde el antígeno de la enfermedad infecciosa comprende una proteína.
MX2012003180A 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino. MX347154B (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
US14/380,863 US9284360B2 (en) 2012-02-24 2013-02-21 Diagnostic test for infectious diseases in cattle
PCT/MX2013/000025 WO2013125936A2 (es) 2012-02-24 2013-02-21 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Publications (2)

Publication Number Publication Date
MX2012003180A MX2012003180A (es) 2013-08-27
MX347154B true MX347154B (es) 2017-02-21

Family

ID=49006336

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003180A MX347154B (es) 2012-02-24 2012-02-24 Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.

Country Status (3)

Country Link
US (1) US9284360B2 (es)
MX (1) MX347154B (es)
WO (1) WO2013125936A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020005704A (es) * 2020-07-13 2022-01-14 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Secuencias de dominios vnar de potamotrygon spp. como inmunoacarreadores anti-cancer.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
EP0646173A4 (en) * 1992-05-22 1997-02-26 Agen Ltd REAGENT FOR MEASURING AGGLUTINATION.
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
CZ302870B6 (cs) 1998-04-07 2011-12-28 Corixa Corporation Polynukleotid, polypeptid, farmaceutický prostredek, vakcínový prostredek a jejich použití k lécbe a prevenci infekce tuberkulózou
DE69941545D1 (de) 1998-11-04 2009-11-26 Isis Innovation Tuberkulose diagnose test
AU6867801A (en) 2000-06-20 2002-01-02 Corixa Corp Fusion proteins of mycobacterium tuberculosis
WO2005118629A1 (en) 2004-06-02 2005-12-15 Diatech Pty Ltd BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
US20060024332A1 (en) 2004-08-02 2006-02-02 Waters Wade R Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
WO2011056056A2 (es) 2009-11-04 2011-05-12 Laboratorios Silanes, S.A. De C.V. Dominios vhnar anti -citocinas

Also Published As

Publication number Publication date
WO2013125936A9 (es) 2014-03-13
MX2012003180A (es) 2013-08-27
US9284360B2 (en) 2016-03-15
WO2013125936A3 (es) 2013-10-24
US20150044689A1 (en) 2015-02-12
WO2013125936A2 (es) 2013-08-29

Similar Documents

Publication Publication Date Title
EP4296673A3 (en) Peptides and methods for the detection of lyme disease antibodies
WO2011063003A3 (en) Peptides and methods for the detection of lyme disease antibodies
MX348071B (es) Variantes de fc.
MX381183B (es) Proteínas de fusión de serpina-fc de inmunoglobulina de humano y método de purificación de las mismas.
EA202190266A1 (ru) Рекомбинантные захватывающие белки клеточной поверхности
MY171913A (en) Methods for determining ligand binding to a target protein using a thermal shift assay
BR112015014751A2 (pt) anticorpos anti-tau humanos
EA201490745A1 (ru) Полипептиды антител, которые вызывают антагонизм cd40l
ECSP12012272A (es) Proteínas que se unen al tnf-?
HK1252653A1 (zh) 特异於人hla呈递的ebv潜伏膜蛋白2a肽的t细胞受体样抗体药剂
WO2011002968A3 (en) Polypeptides and method of treatment
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
AU2018249796A1 (en) Antibody Fc variants for improving blood half-life
WO2011156467A3 (en) Methods of detecting residual amounts of polymers used in the purification of biomolecules
CA2735138C (en) Screening methods for transfusion related acute lung injury (trali)
BR112014023063A2 (pt) anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
WO2012126118A8 (en) Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
WO2013138259A3 (en) Polypeptides for treating and/or limiting influenza infection
MX347154B (es) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
WO2011015379A8 (en) Human hcv-interacting proteins and methods of use
PH12012000361B1 (en) Method for detecting flaviviridae virus infection
MX349708B (es) Proteína acarreadora de antígenos para detección de patógenos por medio de hemoaglutinación, proveniente de heterodontus francisci.

Legal Events

Date Code Title Description
FG Grant or registration